Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Natural history, treatment, and course of papillary thyroid carcinoma

Journal Article · · Journal of Clinical Endocrinology and Metabolism; (USA)

We have analyzed the course of papillary thyroid carcinoma in 269 patients managed at the University of Chicago, with an average follow-up period of 12 yr from the time of diagnosis. Patients were categorized by clinical class; I, with intrathyroidal disease; II, with cervical nodal metastases; III, with extrathyroidal invasion; and IV, with distant metastases. Half of the patients had a history of thyroid enlargement known, on the average, for over 3 yr. In 15% of patients given thyroid hormone, the mass decreased in size. The peak incidence of cancer was when subjects were between 20-40 yr of age. Tumors averaged 2.4 cm in size; 21.6% had tumor capsule invasion, and 46% of patients had multifocal tumors. Sixty-six percent of the patients had near-total or total thyroidectomy. The overall incidence of postoperative hypoparathyroidism was 8.4%, but the incidence was zero in 83 near-total or total thyroidectomies carried out by 1 surgeon. Twenty-five percent of the patients had continuing or recurrent disease, and 8.2% died from cancer. Deaths occurred largely in patients with class III or IV disease. Cervical lymph nodes were associated with increased recurrences, but not increased deaths. Extrathyroidal invasion carried an increased risk of 5.8-fold for death, and distant metastases increased this risk 47-fold. Age over 45 yr at diagnosis increased the risk of death 32-fold. Tumor size over 3 cm increased the risk of death 5.8-fold. Surgical treatment combining lobectomy plus at least contralateral subtotal thyroidectomy was associated, by Cox proportional hazard analysis, with decreased risk of death in patients with tumors larger than 1 cm and decreased risk of recurrence among all patients, including patients in classes I and II, compared to patients who underwent unilateral thyroid surgery or bilateral subtotal resections.

OSTI ID:
6617652
Journal Information:
Journal of Clinical Endocrinology and Metabolism; (USA), Journal Name: Journal of Clinical Endocrinology and Metabolism; (USA) Vol. 71:2; ISSN JCEMA; ISSN 0021-972X
Country of Publication:
United States
Language:
English

Similar Records

Not all occult papillary carcinomas are minimal
Journal Article · Wed Nov 30 23:00:00 EST 1988 · Surgery; (United States) · OSTI ID:6610694

Selective postoperative radioactive iodine treatment of thyroid carcinoma
Journal Article · Thu Nov 30 23:00:00 EST 1989 · Surgery; (USA) · OSTI ID:5026830

Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients
Journal Article · Sat Feb 28 23:00:00 EST 1981 · Am. J. Med.; (United States) · OSTI ID:5762417